First-line high-dose therapy and autologous blood stem cell transplantation in patients with primary central nervous system non-Hodgkin lymphomas-a single-centre experience in 61 patients
- Publication date
- 1 January 2022
- Publisher
- 'Springer Science and Business Media LLC'